vomiting

News

The FDA has delivered some end-of-year cheer to Vanda Pharma after approving Nereus, its drug for the prevention of motion sickness.

News

Japanese pharma also hands back rights to painkiller to US biotech.

News

Pharvaris has reported positive data from a phase 3 trial of its drug for preventing HAE attacks, setting up marketing applications next year.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.